Effects of transdermal flunixin meglumine on pain biomarkers at dehorning

Authors

  • M. D. Kleinhenz Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA 50011
  • N. K. Van Engen Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA 50011
  • P. J. Gorden Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA 50011
  • J. F. Coetzee Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA 50011

DOI:

https://doi.org/10.21423/aabppro20163470

Keywords:

Dehorning, dairy cattle, animal welfare, NSAID, topical drug, flunixin, pain

Abstract

Dehorning is a common procedure performed on over 90% of dairy farms. The increasing awareness of animal welfare and pain mitigation have made the use of nonsteroidal anti-inflammatory drugs (NSAIDs) common and desirable at the time of dehorning. Recently, a novel formulation of flunixin meglumine has been developed and approved in the European Union. This novel formulation is designed for topical application and transdermal absorption of the active ingredient. The objective of this study was to evaluate the analgesic effects of topical flunixin meglumine when given at the time of dehorning on pain biomarkers.

Cover image of the 49th Conference Proceedings: An image of a herd of Angus cattle grazing in a field at dusk. Yellow background.

Downloads

Published

2016-09-15

Issue

2016

Section

Research Summaries 2